Business
Cochlear (ASX:COH) share price in focus after delivering a solid half year result
The Cochlear Limited (ASX: COH) share price will be on watch today following the release of its half year results.
How did Cochlear perform during the first half?
Cochlear’s performance continued to improve during the first half of FY 2021 after surgeries recovered following COVID-19 related shutdowns. Management notes that the pace of recovery varied across markets, with strong growth recorded in the United States, Japan, Korea, and China. This was supported by improving momentum in Western Europe, which partially offset a slower recovery in emerging markets.
For the six months ended 31 December, Cochlear reported a 4% (or 1% in constant currency) decline in sales to $742.8 million. This was driven by a 7% increase in second…
-
Business12 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business16 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business8 hours agoDicker Data rides the AI trend to double digit growth
-
General21 hours agoDenmark summons US envoy over suspected influence operations in Greenland